These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Production of autologous keratinocytes for therapeutic purposes within a pharmaceutical company]. Guillot FL J Soc Biol; 2001; 195(1):75-7. PubMed ID: 11530505 [TBL] [Abstract][Full Text] [Related]
3. The effects of age on monolayer culture of human keratinocytes for future use in skin engineering. Muhd Fakhruddin BH; Aminuddin BS; Mazlyzam AL; Ruszymah BH Med J Malaysia; 2004 May; 59 Suppl B():182-3. PubMed ID: 15468878 [TBL] [Abstract][Full Text] [Related]
4. A guide to biological skin substitutes. Jones I; Currie L; Martin R Br J Plast Surg; 2002 Apr; 55(3):185-93. PubMed ID: 12041969 [TBL] [Abstract][Full Text] [Related]
6. Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds. Ehrlich HP Am J Surg; 2004 May; 187(5A):29S-33S. PubMed ID: 15147989 [TBL] [Abstract][Full Text] [Related]
7. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Spiekstra SW; Breetveld M; Rustemeyer T; Scheper RJ; Gibbs S Wound Repair Regen; 2007; 15(5):708-17. PubMed ID: 17971017 [TBL] [Abstract][Full Text] [Related]
8. Biologic dressings. Junkins-Hopkins JM J Am Acad Dermatol; 2011 Jan; 64(1):e5-7. PubMed ID: 21167402 [No Abstract] [Full Text] [Related]
9. Keratin expression in cultured skin substitutes suggests that the hyperproliferative phenotype observed in vitro is normalized after grafting. Smiley AK; Klingenberg JM; Boyce ST; Supp DM Burns; 2006 Mar; 32(2):135-8. PubMed ID: 16455203 [TBL] [Abstract][Full Text] [Related]
10. [Skin substitutes reconstructed in the laboratory: application in burn treatment]. Braye F; Hautier A; Bouez C; Damour O Pathol Biol (Paris); 2005 Dec; 53(10):613-7. PubMed ID: 16364813 [TBL] [Abstract][Full Text] [Related]
11. What is the future in wound dressing technology? Nurs RSA; 1994 Jul; 9(7):20. PubMed ID: 7969378 [No Abstract] [Full Text] [Related]
12. Employing human keratinocytes cultured on macroporous gelatin spheres to treat full thickness-wounds: an in vivo study on athymic rats. Gustafson CJ; Birgisson A; Junker J; Huss F; Salemark L; Johnson H; Kratz G Burns; 2007 Sep; 33(6):726-35. PubMed ID: 17467913 [TBL] [Abstract][Full Text] [Related]
14. Closure of the excised burn wound: autografts, semipermanent skin substitutes, and permanent skin substitutes. Sheridan R Clin Plast Surg; 2009 Oct; 36(4):643-51. PubMed ID: 19793558 [TBL] [Abstract][Full Text] [Related]
15. The role of tissue engineering in wound care. Mulder GT J Wound Care; 1999 Jan; 8(1):21-4. PubMed ID: 10214195 [No Abstract] [Full Text] [Related]
16. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice. Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745 [TBL] [Abstract][Full Text] [Related]
17. New skin-equivalent model from de-epithelialized amnion membrane. Yang L; Shirakata Y; Shudou M; Dai X; Tokumaru S; Hirakawa S; Sayama K; Hamuro J; Hashimoto K Cell Tissue Res; 2006 Oct; 326(1):69-77. PubMed ID: 16758181 [TBL] [Abstract][Full Text] [Related]
18. Combined use of a collagen-based dermal substitute and a fibrin-based cultured epithelium: a step toward a total skin replacement for acute wounds. Mis B; Rolland E; Ronfard V Burns; 2004 Nov; 30(7):713-9. PubMed ID: 15475148 [TBL] [Abstract][Full Text] [Related]